"I wouldn't really believe statistics" - Challenges with influenza vaccine acceptance among healthcare workers in Singapore. by Sundaram, Neisha et al.
Sundaram, Neisha; Duckett, Kathryn; Yung, Chee Fu; Thoon, Koh
Cheng; Sidharta, Sucitro; Venkatachalam, Indumathi; Chow, Angela;
Yoong, Joanne (2018) ”I wouldn’t really believe statistics” - Chal-
lenges with influenza vaccine acceptance among healthcare workers
in Singapore. VACCINE, 36 (15). pp. 1996-2004. ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2018.02.102
Downloaded from: http://researchonline.lshtm.ac.uk/4650494/
DOI: 10.1016/j.vaccine.2018.02.102
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
‘‘I wouldn’t really believe statistics” – Challenges with influenza vaccine
acceptance among healthcare workers in Singapore
Neisha Sundaram a,b,⇑, Kathryn Duckett a, Chee Fu Yung c, Koh Cheng Thoon c,d, Sucitro Sidharta a,
Indumathi Venkatachalam e,1, Angela Chow a,f, Joanne Yoong a,g
a Saw Swee Hock School of Public Health, National University of Singapore, 12 Science Drive 2, #10-01, Singapore 117549, Singapore
bDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
c Infectious Disease Service, Department of Paediatrics, KK Women’s and Children’s Hospital, 100 Bukit Timah Road, Singapore 229899, Singapore
dDuke-NUS Graduate School of Medicine, National University of Singapore, 8 College Road, Singapore 169857, Singapore
eDivision of Infectious Disease, National University Hospital, 5 Lower Kent Ridge Road, Singapore 119074, Singapore
fDepartment of Clinical Epidemiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore
gCenter for Economic and Social Research, University of Southern California, 1909 K Street, Washington, DC 20006, United States
a r t i c l e i n f o
Article history:
Received 25 October 2017
Received in revised form 21 February 2018
Accepted 23 February 2018
Available online 5 March 2018
Keywords:
Influenza vaccine
Vaccine hesitancy
Healthcare worker
Qualitative
Occupational vaccination
Health services research
a b s t r a c t
Background: Influenza vaccine acceptance among healthcare workers (HCWs) is a worldwide problem,
but relatively little research has focussed on Asia, including Singapore. Despite widespread access and
recommendations from public health authorities, influenza vaccine uptake remains suboptimal among
HCWs.
Methods: Our qualitative study used focus group discussions to identify and explain factors limiting
influenza vaccine acceptance among HCWs in Singapore. A total of 73 doctors, nurses, allied health
and ancillary staff across three public hospitals were included.
Results: Challenges identified include a fear of contracting influenza from vaccination exacerbated by
negative anecdotes regarding vaccine safety and efficacy, distrust of published efficacy data, uncertainty
regarding relevance of existing data for Singapore, reluctance to introduce chemicals or overmedicate,
pain from injection, low risk attributed to influenza and limited awareness of influenza transmission with
a preference for alternatives in patient protection. Differences in attitudes were observed across voca-
tional groups. Lack of overt promotion by hospital leadership in some institutions, perceived vaccine
hesitancy among doctors, access, and work culture that implicitly encourages working through illness
were further barriers.
Conclusion: Our findings highlight a combination of misperceptions about influenza vaccination and cog-
nitive biases at the individual level, and challenges at the institutional level limiting uptake. Findings
indicate an urgent need to provide targeted education and communication. Rather than providing more
data, we recommend a widely-disseminated, locally-compiled synthesis addressing specific concerns of
hesitant HCWs. Tailoring interventions to specific vocational groups should be considered. Institutional
norms and culture may have a powerful influence in setting default behaviours: more effort is needed
in improving influenza vaccine promotion and priority at some institutions, integrating vaccine-related
communication with other infection control communication and addressing influenza vaccine hesitancy
among doctors as a priority. Finally, further study of strategies to address cognitive biases affecting influ-
enza vaccine acceptance in Singapore is desirable.
 2018 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Influenza vaccination is recommended for health care workers
(HCWs) as they are at increased risk of exposure to influenza virus
and may play a key role in transmission to patients [1,2]. In addi-
tion to infection prevention and decreased staff absenteeism [3],
improving influenza vaccine acceptance enhances hospital pan-
demic response, as seasonal influenza vaccine uptake has consis-
tently been shown to predict pandemic influenza vaccine uptake
[4–7]. Despite presumably higher knowledge of infectious diseases,
poor uptake among HCWs has been noted worldwide [8,9]. Issues
with access to influenza vaccine have been highlighted [10], accep-
tance, however, requires equal attention.
A number of factors limit influenza vaccine uptake among
HCWs: perception of influenza as a mild disease, a lack of per-
ceived personal risk, concerns regarding vaccine safety and efficacy
and inconvenient access [8,9]. The behavioural economics litera-
ture provides additional insights regarding the role of cognitive
biases in vaccination decision-making [11]. Most of these studies,
however, have been conducted outside of Asia. The few studies
in Asia have found similar reasons affecting influenza vaccine
acceptance such as perception of influenza as not serious and con-
cerns with vaccine safety and efficacy among others [12–14]. How-
ever, a deeper exploration of themes underlying these reasons and
a more nuanced understanding of vaccine hesitancy beyond the
acceptance-rejection dichotomy is lacking.
Vaccine hesitancy as defined by the SAGE Working Group on
Vaccine Hesitancy refers to a ‘‘delay in acceptance or refusal of
vaccination despite availability of vaccination services” [15]. It
is believed to be influenced by factors such as complacency,
convenience and confidence and is formulated as a behavioural
phenomenon which is vaccine and context specific [15]. How-
ever, this definition is limited insofar as it does not adequately
address the link between attitudinal factors and behaviour
[16,17]. In our study, in addition to exploring psychological
aspects of vaccine hesitancy, we explore institution-based cul-
tural factors, social factors and potential access-related barriers.
We seek to identify and explain factors of practical utility that
may limit influenza vaccine acceptance among HCWs in
Singapore.
As a tropical country, Singapore does not have well-defined
influenza seasons, but faces a substantial influenza burden with
an estimated 20% of the population infected each year and mor-
tality comparable to that in the United States [18,19]. Vaccination
rates among HCWs in Singapore are less than desired [20] and
vary considerably (39–66%) across different healthcare institu-
tions and time periods [14,20,21]. Past experience with the
2003 SARS epidemic, continuing vulnerability to emerging infec-
tious diseases as a highly-connected travel hub and committed
leadership have together ensured efficient handling of disease
outbreaks and a population that is largely responsive to recom-
mended public health measures [22–25]. Seasonal influenza vac-
cine uptake, however, remains an exception despite Ministry of
Health recommendations for HCW vaccination [26,27] and provi-
sion of vaccines to HCW for free in all major healthcare
institutions.
Vaccine hesitancy and acceptance among HCWs is especially
important to understand and address as HCWs directly influence
public opinion, community vaccine acceptance and decision-
making on vaccination [28,29]. Our research is formulated as a case
study for Singapore that aims to identify and explain factors that
limit influenza vaccine acceptance among HCWs through an in-
depth qualitative study of doctors, nurses, allied health and ancil-
lary staff across hospitals in Singapore.
2. Methods
2.1. Study setting and design
Qualitative focus group discussions (FGDs) explored percep-
tions of influenza and influenza vaccines, and facilitators and bar-
riers to influenza vaccine acceptance across three of sixteen public
hospitals and specialty centres in Singapore [30] in a case study
design. These three organizations were selected to cover general
tertiary care and infectious disease in adult and paediatric settings,
to ensure a wide representation of patient-facing, hospital-based
HCW. This research is part of a larger mixed-methods study of
influenza vaccine uptake in Singapore. Ethical approval: NUS-IRB,
NUS2204.
2.2. Participant selection
Separate FGDs were conducted with hospital-based HCWs from
four vocational categories – doctors, nurses, allied health and ancil-
lary staff. Participants were randomly selected using staff lists
while ensuring a mix of departments/specialities. For example,
an allied health FGD would have one physiotherapist, occupational
therapist, dietitian, pharmacist, medical technician, social worker,
etc. A mix of more junior and senior staff, from different depart-
ments, was maintained. Participants were contacted through
human resources or directly by research staff, as per hospital
policy.
2.3. Instrument and data collection
FGD guide construction was guided by a literature review, dis-
cussion with experts to identify areas of interest and key informant
interviews with persons involved in vaccine policy and delivery.
The FGD guide was pilot-tested and refined before implementa-
tion. Topics covered included perceptions of influenza, participant
priority for preventing influenza and methods used for prevention,
views and experience with influenza vaccine and facilitators and
barriers to vaccine acceptance. The topic guide was used to lead
the discussion in a semi-structured approach, allowing for flexibil-
ity, elaboration and a natural flow of conversation to elicit rich and
valid data. Facilitators presented themselves without any titles or
authority and efforts were made to ensure all participants felt com-
fortable speaking freely. FGDs were facilitated by NS or KD, accom-
panied by a note-taker. Written informed consent was obtained
prior to interview and participants were provided a token reim-
bursement. FGDs were audio recorded with permission.
2.4. Data management and approach to analysis
Data was transcribed verbatim from voice records into MS
Word and enhanced with notes taken and observations made dur-
ing interviews. Transcripts were managed and analysed with qual-
itative data analysis software, MAXQDA 11. Thematic analysis was
performed based on the research question concerning identifying
and explaining factors that may limit influenza vaccine acceptance
among HCWs. For first-level coding, text was coded thematically
using a deductive approach based on topics covered in the FGD
guide and on relevant topics from the influenza vaccine acceptance
literature. Second-level coding made use of an inductive approach
to identify new themes from the data. NS coded the data, which
was reviewed and discussed with JY. NS and JY then jointly devel-
oped a list of themes used for analysis.
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3. Results
Seventy-three healthcare workers—19 doctors, 22 nurses, 20
allied health and 12 ancillary staff—participated in eleven focus
group discussions across three sites (Table 1) conducted between
June 2014 and March 2015. Influenza vaccine was generally con-
sidered a low priority and was ranked below other occupational
vaccines such as hepatitis B or varicella. The exceptions were FGDs
ancillary staff and nurses at site 2, who considered influenza vac-
cine as important as other vaccines. Although ancillary staff from
site 3 and nurses from site 2 considered the vaccine compulsory,
they reported enthusiasm towards receiving it.
Challenges associated with vaccine uptake were categorized
into three broad domains of vaccine-related, disease-related and
institution-related factors. Each domain covered several themes
as follows:
Vaccine-related factors
3.1. Perception that vaccination causes influenza as a side-effect
A frequently mentioned barrier was fear of contracting influ-
enza from vaccination. This belief was widespread among vaccine
acceptors and non-acceptors alike. Acceptors, however, rational-
ized that this unavoidable side-effect was offset by protection
the vaccine provided against serious influenza. For others, antici-
pated illness from vaccination disqualified vaccine use for a num-
ber of reasons (illustrative quotes, Table 2): (a) influenza following
vaccination was considered a certainty, while naturally catching
influenza was not, (b) influenza resulting from vaccination was
considered more severe than naturally-acquired influenza, (c)
influenza following vaccination would result in inability to work
which was of particular concern to doctors and allied health staff
who did not wish to be absent for what they perceived to be an
avoidable reason. Furthermore, such absence was unlikely to be
viewed kindly by superiors and some believed they might be
blamed for it: ‘‘If you get the vaccine and you get sick, it’s your fault”
[FGD1]. The perception that the vaccine causes influenza was men-
tioned in all groups except for those with ancillary staff, who noted
no concerns about illness from vaccination even on probing.
3.2. Concerns regarding vaccine efficacy
Belief that the vaccine did not work was explained in two main
ways as follows (Table 3).
3.2.1. Efficacy data considered unreliable or inadequate
Insufficient local data supporting efficacy of Northern or South-
ern hemisphere vaccines in tropical Singapore with year-round
influenza circulation was a concern. Particularly vaccine hesitant
Table 1
Overview of participant characteristics.
Focus group number Professional category Site Number of participants Percentage of men Mean age (years) Influenza vaccine receipt (number)a
1 Doctors 1 7 71% 30.9 5
2 Nurses 1 5 0% 34.0 4
3 Allied health staff 1 7 29% 34.9 3
4 Ancillary staff 1 7 100% 54.9 6
5 Doctors 2 7 86% 31.9 4
6 Nurses 2 9 0% 36.1 9
7 Allied health staff 2 5 20% 31.4 2
8 Doctors 3 5 20% 27.3 0
9 Nurses 3 8 0% 46.5 5
10 Allied health staff 3 8 13% 31.3 6
11 Ancillary staff 3 5 0% 49.0 5
Total 73 32% 37.2 49
Ancillary staff included porters, patient care assistants, housekeepers, general service and security personnel.
a Refers to number of participants who mentioned having taking the influenza vaccine in the past year.
Table 2
Analysis of concerns related to the perception that influenza vaccination causes influenza as a side-effect.
List of sub-themes for the perception that influenza vaccination
causes the flu and resulting vaccine hesitancy
Illustrative quotes
Perception that flu is a guaranteed side-effect of vaccination, while
one may not necessarily catch influenza if not vaccinated
‘‘The first two years when I went for the vaccination, after the vaccination I felt really sick. I usually
don’t get flu at all, like I can’t think of the last time I got flu before I got the vaccination. But after the
vaccination I got really sick - there was flu, there was cough and there was fever. Then last year
when I didn’t get the vaccination I didn’t have anything like that” [Allied health, FGD7]
‘‘I remember around 2006 when Singapore started encouraging people to have the flu vaccine. Those
who had it, about half of them got flu. I didn’t take the flu vaccine, nothing happened to me.”
[Nurses, FGD9]
Perception that flu after vaccination is more severe than naturally-
acquired influenza
‘‘The last few years I have actually found that when I take vaccine I’m sick for two to four weeks after
the vaccine. It can be quite bad and the symptoms seem to be more than the typical kind of flu
symptoms I usually get.”[Allied health, FGD10]
‘‘The last time I got the vaccine was five years ago and after that I had flu anyway. And even worse
[reference to degree of flu]. I had myalgia everywhere, I was really sick after that. So it didn’t work
for me. [Doctors, FGD5]
Concerns regarding absence from work due to flu perceived to be
caused by influenza vaccination
‘‘You may get the actual flu after vaccination, which is severe enough for you to drop work for a
couple of days and that puts people off.” [Doctors, FGD1]
‘‘From what I have heard the feedback isn’t very good. Most people get sick. My friends get sick after
the vaccination. This side effect causes them to think: ‘‘oh! I don’t want to get sick these few days. I
have a heavy work load, so I will not go for it”
[Allied health, FGD3]
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doctors mentioned unconvincing evidence for vaccine efficacy, dis-
trust of published scientific data and a belief that relevant efficacy
data for Singapore can never be obtained (Table 3) as reasons for
non-acceptance. Although discussions regarding questionable or
insufficient evidence were unique to doctors, nurses and allied
health staff also expressed distrust of numeric data: ‘‘I wouldn’t
really believe statistics. They just show me another number and try
to cheat me” [FGD7].
3.2.2. Negative anecdotal or personal experience with vaccine
effectiveness
On the other hand, anecdotes were a generally trusted informa-
tion source, and often more salient evidence of efficacy (or lack
thereof) than research studies. Stories about getting ‘the flu’
despite vaccine receipt were frequently mentioned while explain-
ing vaccine inefficacy. Unmet expectations of the influenza vaccine
preventing all flu-like illnesses contributed to the perception that
the vaccine was ineffective, mostly among doctors and allied
health staff. Conversely, some nurses and ancillary staff appreci-
ated the protection offered by vaccination, while acknowledging
that it may not prevent all flus. While explaining how people
decide to take an influenza vaccine, a participant explained: ‘‘
[Through] knowledge of past stories, stories of other people; so more
testimonials than statistics” [FGD7]. Participants often stated that
their ‘‘gut feeling” influenced their decision-making.
3.3. Reluctance to introduce non-natural substances into the body
Another reason for hesitancy was reluctance to introduce sub-
stances perceived as unnatural (‘‘chemicals”) and a general avoid-
ance of medication (Table 4). This theme was mentioned by
doctors, nurses and allied health, but not ancillary staff (Supple-
mentary Table). Other perceived natural means of enhancing one’s
immunity were often preferred instead, such as getting a cold
every year, a healthy lifestyle or vitamin C supplementation.
3.4. Annual vaccination, inconvenient and painful
Fear of needles or pain from injection was mentioned as a
potential barrier in FGDs, across all vocational categories. Having
to take the vaccine every year was considered troublesome and
also prevented uptake for some. On the other hand, nurses at one
site mentioned valuing receipt of a vaccine tailor-made by scien-
tists each year and ancillary staff considered yearly vaccination
useful for general health promotion.
Disease-related factors
3.5. Influenza not considered a serious disease
Vaccination was not a priority for some doctors, nurses and
allied health staff who perceived influenza as a routine illness
causing temporary inconvenience but no lasting harm. Some did
not consider influenza serious enough to be absent from work,
and took pride in ‘‘powering through it”. A doctor explained: ‘‘Influ-
enza to me is one of many viruses we catch every day. It is routine.
Vaccinating against one of many possible things we may catch seems
illogical to me. Whether I have four episodes of flu or ten, we just work
through it; life carries on” [FGD5]. This view was not held by all.
Those who worked in intensive care units or emergency, those
who had witnessed influenza-related mortality, those who had suf-
Table 3
Analysis of concerns regarding the ability of influenza vaccine to prevent illness.
Illustrative quotes
Efficacy data unreliable or inadequate
Evidence for vaccine efficacy perceived as unconvincing ‘‘It is not something that you can within your mind usually justify the impact on a) your patient and b)
yourself. . .and you know the potential controversies surrounding the efficacy, it’s all of that which holds us
back” [Doctors, FGD5]
‘‘I cannot see any evidence coming up where somebody is going to shove a piece of paper and say this is
the best study ever done, it should convince you. It’s unlikely” [Doctors, FGD5]
Distrust of published data ‘‘We know evidence really does not matter. You can tweak anything that you want. We publish you
know. . .Unless data is pure and clear cut, but most of the time evidence-based medicine is as good as who
is in it to do it actually” [Doctors, FGD1]
Lack of relevant efficacy data for the Singapore context and a
presupposition that such data is unattainable
‘‘I think it would be great to have that evidence. But, I just cannot see it happening. I think it is not feasible
because it is a captive audience, that is within a very small subset of a much bigger population, and to
show that this is what is happening in [site 2] and if you [take the vaccine] it is going to make a difference,
it is not true because no one lives in [site 2]. They all go out and interact in Singapore and they all interact
with Asia-Pacific and the rest of the world.” [Doctors, FGD5]
Negative anecdotal or personal experience with the vaccine
All flu-like episodes not prevented following vaccination ‘‘I took the vaccination the previous time they gave it. It did not really work for me. I don’t feel there is any
difference before and after taking the vaccine” [Allied health, FGD3]
‘‘I don’t really buy into the benefits of this because I still fall sick after taking the jab. I don’t see any value
that is added to me except it has brought me pain and I still fall sick you know.”[Allied health, FGD10]
Table 4
Reluctance to introduce what are perceived to be non-natural chemicals in the body as a reason for influenza vaccine non-acceptance.
Sub-theme Illustrative quotes
Reluctance to introduce substances perceived to be
non-natural in one’s body
‘‘There are some people who believe that they don’t want chemicals in their body. They want everything to be
natural” [Allied health, FGD3]
‘‘I am not very pro-drugs, pro-injections. So if I can avoid taking medication as long as I possibly can, I will”
[Doctors, FGD5]
Reliance on other ways of protecting oneself that are
perceived to be natural
‘‘I think there are other ways to protect myself. . .other natural ways you know—exercise, eat well, sleep well—
instead of getting the jab” [Allied health, FGD10]
‘‘I find having a cold a year might help because it actually boosts your immunity” [Doctors, FGD8]
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fered from a bad case of influenza themselves and ancillary staff,
considered influenza serious and were supportive of vaccination.
3.6. Do not consider oneself vulnerable to influenza
A doctor succinctly noted: ‘‘I don’t think we see ourselves as a
very vulnerable population” [FGD1]. Reasons for not considering
oneself vulnerable were varied (Table 5): (a) perceived high per-
sonal immunity against influenza, (b) not working with patients
perceived to transmit infections and (c) considering oneself too
young to be at risk. This was mentioned in all FGDs with doctors,
and in some FGDs with nurses, allied health and ancillary staff.
3.7. Limited saliency of vaccination in preventing influenza
transmission and patient protection
Those who were positively-inclined towards influenza vaccina-
tion mentioned protecting oneself or one’s family as a key factor in
vaccination decision-making. Patient protection as a reason for
occupational influenza vaccination was seldom mentioned
(Table 6). Some who did consider influenza transmission to
patients focused on transmission from symptomatic individuals
and mentioned alternate means (than vaccination) of preventing
transmission such as masks and avoiding patient contact. A physi-
cian said: ‘‘Why I don’t take it is because I feel that my little neonates
don’t infect me. When I am unwell I wouldn’t expose myself to the chil-
dren” [FGD8]. When specifically asked whether professional
responsibility would motivate uptake, many did not see the value
of vaccinating themselves in preventing transmission and some
doctors cited questionable evidence from recent studies. Particu-
larly vaccine hesitant doctors did not believe influenza-related
morbidity in patients was a concern, while some allied health staff
felt patients ought to be vaccinated instead as they primarily trans-
mit infections to HCWs. Ancillary staff, however, mentioned
patient protection spontaneously as a reason for vaccination at
both FGDs. Vaccinating oneself for patient safety was also cited
more frequently among nurses than allied health staff or doctors.
Institution-related factors
3.8. Access
Access was in general not a frequently mentioned barrier. Inad-
equate vaccine stock, short campaign duration and absence of a
hospital clinic to get the vaccine outside of a campaign were barri-
ers mentioned in one site. No particular concerns were noted in the
other two sites. Doctors in all sites thought making access more
convenient would improve uptake, while ancillary staff in both
sites considered the existing delivery process highly convenient.
3.9. Insufficient institutional endorsement and leadership by example
In sites 1 and 3, lack of official, explicit promotion by institu-
tional or departmental leadership was cited for vaccine non-
acceptance among doctors and allied health staff. Some viewed it
as an indication of poor efficacy: ‘‘Maybe they also recognize that
it is not really 100% proven that is why they are not pushing everyone
to go for it” [FGD10]. Poor uptake among doctors, who are perceived
as knowledgeable role-models, made nurses in site 3 suspicious of
vaccine safety: ‘‘Is there an effect that we are not being told about or
maybe one that will affect us 10 years down the road” [FGD9]. Con-
versely, an official recommendation was considered difficult to
reject and likely to motivate uptake.
Participants also seemed to infer the priority place on vaccina-
tion by their employers from institutional communications. Partic-
ipants from two sites mentioned use of other means of influenza
prevention, namely handwashing and facemasks, which they
Table 5
Reasons healthcare workers do not consider themselves vulnerable to influenza.
Reasons Illustrative quotes
Personal immunity perceived to be high ‘‘I would like to think my reserves [reference to immunity] are reasonable at the moment”. [Doctors, FGD5]
Do not work with patients perceived to transmit infections ‘‘Personally I don’t take it because I am a neonatologist so I don’t meet with coughing children” [Doctors,
FGD8]
Consider selves too young to be at-risk of catching influenza
or suffering serious consequences from it
‘‘I don’t feel vulnerable because I am at an age group where I am still healthy, so I don’t take up the
vaccination because I just don’t feel the need”. [Doctors, FGD8]
‘‘If an elderly family member gets the flu, I will be very worried for them because in their age group there is a
higher morbidity and mortality rate. So I would strongly advise them to go for vaccination. But personally for
myself I don’t see the need for it because I don’t get serious side effects from the flu. . .so personally we are not
very worried but are more worried for other people” [Allied health, FGD3]
Table 6
Reasons why the goal of patient protection does not currently motivate influenza vaccine uptake.
Sub-theme Illustrative quotes
Not aware that vaccinating oneself could protect patients ‘‘It never crossed my mind so far”[Allied health, FGD10]
Use of alternate means of patient protection such as facemasks
or avoiding contact with patients when ill
‘‘There could be other ways of being responsible other than taking vaccination. So if we know we are sick
then we either wear a mask or don’t come in to work or we try not to go to high risk areas like ICU” [Allied
health, FGD10]
‘‘If I am sick I avoid contact with patients. That is my way of being responsible.”[Allied health, FGD7]
Belief that vaccinating oneself would not prevent transmission
to patients
‘‘If I believed that it helped it would help prevent me spreading it then I would take it. But I don’t believe it
so that is why.”[Allied health, FGD7]
Influenza not perceived to be a major cause of morbidity
among patients encountered
‘‘I cannot justify in my mind that me getting influenza vaccination is going to help my patients. If my
patients are going to go downhill there are 101 other reasons for it. Influenza is probably not going to be the
in top 100 - not in my patient cohort.” [Doctors, FGD5]
Belief that patients have a responsibility to protect themselves ‘‘They pass it [reference to infections] to us. Patients must have the flu vaccine.” [Allied health, FGD7]
‘‘I think it is not just about the health care workers but about the patients who come to us. So it might be
good to have a vaccination policy in place for patients in high risk groups” [Allied health, FGD3]
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perceived as alternative options with higher priority than influenza
vaccination, based on their presentation as high-publicity
campaigns by their institutions.
4. Discussion
Vaccines, including influenza vaccines, are considered a key
enabler for the global community’s aspirations to a grand conver-
gence in health [31,32]. It is, however, predicted to be accompa-
nied by an increase in vaccine hesitancy [33]. Vaccine confidence
among HCWs in particular is important not just for provider and
patient protection, but as an indicator of attitudes in society at
large [34]. Unique to this study was eliciting meaning underlying
influenza vaccine hesitancy among HCWs and uncovering chal-
lenges specific to an Asian context.
Findings highlight some common misperceptions about influ-
enza and influenza vaccine among HCWs. A striking finding was
both vaccine acceptors and refusers believed that influenza was a
near certain consequence of vaccination, although adverse effects
of fever, malaise and myalgia are known to affect only 5% of young
children and even fewer adults [1]. A recent study in Germany
found that only 2% of hospital workers reported work-time lost
from adverse events following influenza vaccination [36]. An
explanation for the widely-held perception that the vaccine causes
influenza among Singaporean HCWs could be the availability
heuristic [37], or the tendency to ascribe a high probability to side
effects from influenza vaccination since they are easy to recall and
are often discussed. Various misconceptions about potential sever-
ity of influenza and one’s susceptibility to it also prevented vaccine
uptake. Doctors in particular were subject to overconfidence or
optimism bias, which refers to a cognitive bias of believing that
the risk of suffering from influenza is greater for others than for
oneself [11].
In a recent correspondence, Goldstein et al. ask if the way to
decrease anti-vaccine sentiment is by ‘‘citing more data?” [41].
The answer in this context may be no. Concerns regarding efficacy
and safety are widely documented in the HCW influenza vaccine
hesitancy literature [4,42,43]. In this study, further exploration
revealed that efficacy estimates were less of a concern for doctors
than deeper issues surrounding trust in the scientific enterprise
and relevance of existing data to the local context. Insufficient trust
in scientific evidence was mentioned by the particularly vaccine
hesitant who perhaps used overt criticism of vaccine data to
rationalize their hesitancy. Improving uptake among this group is
likely very challenging. Simply reiterating information in the face
of resistance may lead to a ‘‘backfire effect”, whereby challenging
strongly-held beliefs can further strengthen those beliefs. Rele-
vance of existing international data for tropical Singapore, how-
ever, was mentioned by doctors with legitimate concerns around
choice of Northern or Southern hemisphere vaccines in equatorial
Singapore and uncertainty around the efficacy of influenza vacci-
nes for patient protection in long-term care institutions as high-
lighted in recent meta-analyses [44,45].2 Although not directly
related to scientific evidence, generalised uncertainty about influ-
enza vaccines prevailed among other groups of HCW too. We
hypothesize that even among HCW who are supportive of other
occupational vaccines, uncertainty around influenza vaccines exac-
erbates cognitive biases of omission bias and ambiguity aversion
[11] and they may choose to not take influenza vaccine despite pro-
ven benefits relative to remaining unprotected. Omission bias refers
to the tendency to choose a potentially harmful inaction (in this case
to remain unvaccinated and have greater risk of disease) over a
potentially less harmful action (to vaccinate but potentially suffer
from vaccine side-effects), while ambiguity aversion manifests as a
preference for known risk (a greater risk of disease if unvaccinated)
to an unknown risk (side-effects from vaccination not well-
understood).
What may be required therefore is not necessarily more data,
but more transparency—including a locally-compiled, simple and
widely-disseminated, professional synthesis, specifically targeting
doctors. Such a synthesis should explicitly acknowledge and
address uncertainties around quality of evidence with an explana-
tion for why influenza vaccines are nevertheless recommended,
along with an explanation of the consequences of cognitive biases.
Presenting similar syntheses to other vocational groups, such as
allied health staff, with less emphasis on evidence, may also be
useful.
Although education has improved influenza vaccine uptake
among HCWs in other studies [38,39], our findings suggest that
an effective strategy for Singapore may involve education incorpo-
rating vivid evidence through stories from individuals who have
witnessed serious influenza personally or in others; especially as
our findings suggest that anecdotes are considered universally
compelling evidence, while numbers and statistics were less con-
vincing and on the contrary often viewed with suspicion. As iden-
tified in other vaccine communication research, these stories
should communicate a clear gist or bottom-line message in order
to be compelling [40].
Shunning influenza vaccines for being ‘‘unnatural” or a form of
overmedication was noted in this study. Following from this
theme, prophylactic vitamin C supplements were widely preferred
as a natural prevention method, despite the proven ability of only
vaccines to prevent influenza by producing a ‘‘natural” immune
response. Again while education is required, efforts to rebrand
influenza vaccine as a natural way to reduce unnecessary prescrip-
tion and antibiotic use, may be a worthwhile approach and aligned
with tackling the global problem of antibiotic overuse [48].
In their review, Hollmeyer et al. found that self-protection was
the most important reason for influenza vaccination reported by
HCWs [9]. We find that HCWs in Singapore differ. Those who were
positively inclined to influenza vaccination prioritized protecting
one’s family in addition to oneself (consistent with findings previ-
ously reported for pandemic influenza vaccine acceptance [39]).
Emphasising the benefits of vaccinating oneself to potentially pro-
tect one’s family may improve uptake in Singapore.
Protecting patients was often not considered and some, includ-
ing doctors working with vulnerable patients, did not consider
asymptomatic transmission (a recent study showed that a large
proportion of HCWs with laboratory-confirmed influenza were
afebrile [49]). This may be a reflection of institutional influenza
vaccine promotion that focuses on self-protection perhaps because
the evidence for patient protection is not yet conclusive. However,
evidence for use of masks in patient protection is not conclusive
either [50], yet masks appeared to be prioritized at some institu-
tions leading some HCW to believe they were a superior alterna-
tive. Adoption of one seemingly more visually-powerful
behaviour to protect patients seems to impede adoption of others
such as vaccination. Institutions thus need to be mindful of how
they communicate with their HCWs: vertical programme-based
communication may be less effective than a more integrated, com-
prehensive approach. Finally, very hesitant HCWs thought that
patients should be responsible for their own health and patients
should be vaccinated instead - tackling this issue requires further
2 Unfortunately, conclusions of these meta-analyses are based on unavailability of
high quality evidence from placebo-controlled trials. However, such evidence is very
difficult to collect as they would generally be considered unethical to conduct among
a high-risk group of HCWs for whom vaccination is recommended (Ortiz JR, Jackson,
ML, Hombach J. Announcing the Publication of a WHO Guide to the Design and
Interpretation of Observational Influenza Vaccine Effectiveness Studies, Clinical
Infectious Diseases, 2017;65:352). Therefore, recommendations are largely-based
on observational studies which provide good evidence of the benefits of influenza
vaccination not only for HCWs but also for their patients.
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study and would likely require inculcating sensitivity towards
patient protection perhaps earlier on during professional
training [51].
Institution-related factors of problems with access identified in
one site requires resource investment - specifically, establishing a
hospital clinic offering the vaccine beyond the campaign duration.
Improving convenience of access has been shown to improve influ-
enza vaccination rates among HCW [21]. However, inconvenient
access is not the only problem: some HCWs were unwilling to even
try the vaccine (which they believed would cause influenza) due to
a culture of heavy workloads, superiors disapproving of flu-related
absence and taking pride in powering through illness. This finding
highlights aspects of Singaporean work culture affecting vaccine
uptake, especially as influenza vaccination has been shown to
reduce illness-related absenteeism [20] and other research has
found that such ‘presenteeism’ or going to work when sick can sig-
nificantly increase workplace influenza transmission [52].
More fundamentally, institutional culture and norms have a
strong influence in setting default behaviours. Perceived lack of
priority for influenza vaccination in some institutions serve as a
‘cue to inaction’, while the attitudes and behaviour of doctors or
senior HCWs towards influenza vaccination indirectly influence
behaviour of other HCWs. This finding is supported by studies con-
ducted elsewhere [35,53]. A study in England found that early
career doctors were likely to ‘‘copy” behaviours of a senior doctor,
even when they were aware that such behaviour conflicts with
infection control procedures [53]. Research in other settings have
found that understanding of such cultural and social norms can
be used to design interventions such as having lead advocates for
influenza vaccine promotion and physician recommendation of
the vaccine to other HCW, which have been effective in improving
influenza vaccine uptake among HCW [54–56]. A study in Spain
found that a high level of institutional support with hospital man-
agement making a public and personal commitment to be vacci-
nated improved vaccination rates along with other strategies
[57]. In order to build influenza vaccine confidence among staff
in Singapore it is critical that institutions themselves do not appear
hesitant and provide public leadership. Doctors in particular hold a
critical position as role-models to other staff and it is imperative
that influenza vaccine hesitancy among doctors is addressed as a
priority.
In general, systematic reviews evaluating interventions to
improve influenza vaccine uptake among HCW have found that
interventions with multiple components are much more effective
that single strategy intervention at improving influenza vaccine
uptake [46,47] and they merit evaluation in Singapore. Further
consideration of cognitive biases affecting influenza vaccine accep-
tance is also relevant, especially as research on strategies to allevi-
ate these biases affecting vaccine uptake is scarce in Singapore.
Strategies aiming to address these biases in other settings have
included use of incentives, securing commitment with reminders
and various social norm approaches such as tailored gain or loss
message framing to improve vaccine uptake [11].
Distinct subcultures were observed among HCWs, which may
be influenced by the relatively hierarchical nature of the Singa-
porean setting. Ancillary staff were least critical, consistent with
previous research where ancillary staff in Singapore had higher
influenza vaccination rates than other staff [14]. Notwithstanding
large social and cultural differences between ancillary staff in their
role as hospital cleaners and porters, compared to other groups of
HCW, they represent a notable example of positive attitudes
towards influenza vaccination worth further study. Extrinsic moti-
vators of believing the vaccine as compulsory or emphasis by man-
agers may be relevant, but intrinsic motivators including
professional pride in the HCW privilege of receiving influenza vac-
cine should not be overlooked. Nurses at one institution had simi-
larly positive views on influenza vaccination, while ancillary staff
and nurses at all institutions seemed more conscious of the con-
cept of patient protection than other vocational groups. Research
in other settings point to large differences in attitudes concerning
influenza vaccination among HCW worker vocational groups
[35,58,59] and doctors have been found to have higher trust in
influenza vaccines than nurses [59]. Our findings suggest that
regardless of their actual uptake, doctors were not necessarily less
prone to misperceptions about influenza vaccination. In fact doc-
tors and allied health staff were more likely to more vocally
express concerns with influenza vaccination. There is evidence to
suggest that tailoring content of educational material and inter-
ventions for specific HCW groups can improve uptake [46]. The
approach to tackling hesitancy in Singapore may benefit from
catering to attitudes and beliefs of different staff groups rather
than assuming that ‘one-size fits all’ in vaccine promotion.
A strength of our FGDs were that participants felt comfortable
expressing their concerns with occupational influenza vaccination,
a fairly sensitive topic, and group dynamics enabled sharing of neg-
ative views in addition to the positive. However, a methodological
consideration to bear in mind is that irrespective of actual beha-
viour, holding a vaccine-sceptic view seemed to be more
attention-grabbing. Care thus needs to be taken to ensure that
the research process does not negatively influence future vaccina-
tion behaviour.
Notwithstanding efforts to ensure random selection, potential
selection bias among participants attending FGDs is a study limita-
tion. Comparisons across vocational groups should therefore be
made sparingly. The study design does not allow for assessing fre-
quency of reasons generalized to the larger HCWs population and
included only HCWs from public hospitals. Nevertheless, a rela-
tively large number of participants included in this qualitative
study, representation of views from a wide range of patient-
facing HCWs from three hospitals in an Asian country and an in-
depth understanding of reasons HCWs may not take an influenza
vaccine are key strengths of this exploratory study.
5. Conclusion
This study identified a number of challenges affecting influenza
vaccine acceptance among HCW in Singapore. To increase vaccine
uptake we recommend a multi-component strategy: On an indi-
vidual level, education programmes should incorporate stories
and other vivid forms of evidence, while rebranding influenza vac-
cine as a natural way to reduce reliance on antibiotics, and empha-
sizing the benefits of vaccination for protecting one’s family. At an
institutional level the following are recommended: public leader-
ship endorsing influenza vaccines, engaging physicians as lead
advocates in vaccine recommendation, changing some institu-
tional norms regarding working through illness and integrating
vaccine communication with other infection control communica-
tion. Finally, further research is needed to tailor interventions to
specific vocational groups and to explore strategies to address cog-
nitive biases that may affect influenza vaccine acceptance in
Singapore.
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